| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.03B | 36.14B | 35.92B | 36.89B | 36.69B | 38.22B |
| Gross Profit | 21.36B | 20.87B | 21.00B | 21.44B | 19.96B | 19.99B |
| EBITDA | 727.13M | 1.25B | 1.44B | 1.40B | -1.85B | -2.36B |
| Net Income | 89.33M | 670.01M | 405.62M | 247.06M | -7.90B | -4.88B |
Balance Sheet | ||||||
| Total Assets | 41.04B | 43.51B | 47.60B | 48.65B | 51.18B | 58.03B |
| Cash, Cash Equivalents and Short-Term Investments | 7.68B | 10.55B | 13.83B | 14.62B | 12.36B | 11.81B |
| Total Debt | 7.22B | 8.77B | 10.26B | 12.24B | 13.33B | 11.62B |
| Total Liabilities | 18.19B | 19.34B | 23.65B | 24.90B | 27.70B | 26.40B |
| Stockholders Equity | 22.85B | 24.17B | 23.94B | 23.75B | 23.49B | 31.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.02B | 855.91M | 3.92B | -2.03B | -4.78B |
| Operating Cash Flow | 0.00 | -138.95M | 1.28B | 4.17B | -1.82B | -4.20B |
| Investing Cash Flow | 0.00 | -1.19B | 537.58M | -468.93M | 162.94M | -674.73M |
| Financing Cash Flow | 0.00 | -1.95B | -2.60B | -1.44B | 2.20B | 4.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥41.52B | 10.95 | ― | 3.62% | -0.98% | -29.86% | |
72 Outperform | ¥139.45B | 20.46 | ― | 4.49% | 2.21% | 4.36% | |
71 Outperform | ¥122.90B | 24.22 | 5.53% | 6.09% | -1.03% | 4.12% | |
70 Outperform | ¥262.97B | 19.60 | ― | 1.46% | 12.02% | -15.70% | |
68 Neutral | ¥746.94B | 16.45 | 8.48% | 2.02% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥14.23B | -34.34 | ― | 2.24% | 0.49% | -169.64% |